COA Available
Weight ManagementBest Seller
GLP-2 T
Dual GLP-2/GIP Receptor Agonist
Dual receptor agonist combining GLP-2 and GIP pathways for effective weight management and glucose control.
Dosage
2.5–15 mg once weekly
Half-Life
~5 days
MW
4181.53 g/mol
Select Size
Third-Party Tested
COA Included
Research Grade
Certificate of Analysis Available
Every batch of GLP-2 T includes a full third-party COA documenting purity, potency, and quality.
Research Benefits
- Significant weight reduction
- Improved glycemic control
- Reduced appetite
- Enhanced metabolic rate
- Cardiovascular risk reduction
- Improved lipid profiles
For research use only. Not for human consumption. Must be 18+ to purchase.
About GLP-2 T
GLP-2 T activates both GIP and GLP-2 receptors simultaneously, providing complementary mechanisms for metabolic regulation. Clinical trials demonstrate significant sustained weight loss of 15–22% with improved glycemic control and reduced cardiovascular risk factors.
Significant weight reduction
Improved glycemic control
Reduced appetite
Enhanced metabolic rate
Cardiovascular risk reduction
Improved lipid profiles